D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 59 500 KRW -0.83%
Market Cap: 534.5B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note
Dong-A ST Co Ltd
/
Income Statement
/
Operating Income

Dong-A ST Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dong-A ST Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Dong-A ST Co Ltd
KRX:170900
Operating Income
-₩21.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Operating Income
₩72.6B
CAGR 3-Years
-5%
CAGR 5-Years
44%
CAGR 10-Years
0%
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
-₩37.5B
CAGR 3-Years
46%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
₩255.8B
CAGR 3-Years
27%
CAGR 5-Years
23%
CAGR 10-Years
19%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
₩4.2B
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
-14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Operating Income
₩29.3B
CAGR 3-Years
-15%
CAGR 5-Years
24%
CAGR 10-Years
15%
No Stocks Found

Dong-A ST Co Ltd
Glance View

Market Cap
511.6B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
96 510.53 KRW
Undervaluation 38%
Intrinsic Value
Price
D
What is Intrinsic Value?

See Also

What is Dong-A ST Co Ltd's Operating Income?
Operating Income
-21.9B KRW

Based on the financial report for Sep 30, 2024, Dong-A ST Co Ltd's Operating Income amounts to -21.9B KRW.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.